PetVivo (NASDAQ:PETV) Reaches New 52-Week High – Here’s Why

PetVivo Holdings, Inc. (NASDAQ:PETV)’s stock price hit a new 52-week high during trading on Tuesday . The company traded as high as $73.50 and last traded at $73.50, with a volume of 12799 shares traded. The stock had previously closed at $0.78.

PetVivo Stock Performance

The company has a market cap of $22.53 million, a P/E ratio of -1.44 and a beta of 1.13. The firm has a 50 day moving average of $1.02 and a 200-day moving average of $1.06. The company has a quick ratio of 0.47, a current ratio of 0.42 and a debt-to-equity ratio of 0.02.

About PetVivo

PetVivo, Inc, headquartered in Ormond Beach, Florida, is a regenerative biomedical technology company specializing in veterinary applications. The company’s core focus is on developing and commercializing sustained-release intra-articular therapies for animals through its proprietary RediVet injectable micro-plug system. This biodegradable polymer platform is designed to provide controlled release of therapeutic agents directly into joints, targeting osteoarthritis and related inflammatory conditions in companion and performance animals.

PetVivo’s lead product, the RediVet-40 system, has been evaluated in proof-of-concept trials involving canine patients with osteoarthritis.